Literature DB >> 15324616

Management of Chronic Congestive Heart Failure in Children.

Ian Balfour1.   

Abstract

The medical management of congestive heart failure involves manipulating myocardial contractility and loading conditions to achieve optimal performance. Medication may be used to counteract potentially deleterious neurohumoral changes that are associated with congestive heart failure. When appropriate, the correction of the underlying cardiac defect by surgery or catheter intervention is usually the most effective treatment for congestive heart failure in children.

Entities:  

Year:  2004        PMID： 15324616     DOI： 10.1007/s11936-004-0024-5

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN： 1092-8464


  22 in total

Review 1.  Intravenous therapy for advanced heart failure.

Authors:  B Stanek; R Pacher
Journal:  Curr Opin Cardiol       Date:  2000-05       Impact factor: 2.161

2.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

3.  A guide to device selection: cardiac resynchronization therapy alone or in combination with an implantable cardioverter defibrillator.

Authors:  Eric N Prystowsky
Journal:  Rev Cardiovasc Med       Date:  2003       Impact factor: 2.930

4.  Implantable left ventricular assist devices can successfully bridge adolescent patients to transplant.

Authors:  D N Helman; L J Addonizio; D L Morales; K A Catanese; M A Flannery; J M Quagebeur; N M Edwards; M E Galantowicz; M C Oz
Journal:  J Heart Lung Transplant       Date:  2000-02       Impact factor: 10.247

5.  Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

Authors:  M D Flather; S Yusuf; L Køber; M Pfeffer; A Hall; G Murray; C Torp-Pedersen; S Ball; J Pogue; L Moyé; E Braunwald
Journal:  Lancet       Date:  2000-05-06       Impact factor: 79.321

6.  Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction.

Authors:  Philippe Menasché; Albert A Hagège; Jean-Thomas Vilquin; Michel Desnos; Eric Abergel; Bruno Pouzet; Alain Bel; Sorin Sarateanu; Marcio Scorsin; Ketty Schwartz; Patrick Bruneval; Marc Benbunan; Jean-Pierre Marolleau; Denis Duboc
Journal:  J Am Coll Cardiol       Date:  2003-04-02       Impact factor: 24.094

7.  Carvedilol as therapy in pediatric heart failure: an initial multicenter experience.

Authors:  L A Bruns; M K Chrisant; J M Lamour; R E Shaddy; E Pahl; E D Blume; S Hallowell; L J Addonizio; C E Canter
Journal:  J Pediatr       Date:  2001-04       Impact factor: 4.406

8.  Effects of digoxin in infants with congested circulatory state due to a ventricular septal defect.

Authors:  W Berman; S M Yabek; T Dillon; C Niland; S Corlew; D Christensen
Journal:  N Engl J Med       Date:  1983-02-17       Impact factor: 91.245

Review 9.  B-type natriuretic peptides: a diagnostic breakthrough for clinicians.

Authors:  Peter A McCullough; Torbjørn Omland; Alan S Maisel
Journal:  Rev Cardiovasc Med       Date:  2003       Impact factor: 2.930

10.  The effect of treatment with angiotensin-converting enzyme inhibitors on survival of pediatric patients with dilated cardiomyopathy.

Authors:  A B Lewis; M Chabot
Journal:  Pediatr Cardiol       Date:  1993-01       Impact factor: 1.655
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.